The Register · A provider

Hospital Ampang

Specialties

clinical research haematology oncology first-in-human studies hematopoietic stem cell transplantation hematological conditions hematology

Clinical Trial Access in Malaysia: National referral centre for haemato-malignancies with 701 beds. Received Phase I accreditation in 2024. Focuses on haematology and oncology first-in-human studies.
Stem Cell Legality in Malaysia: National HSCT referral center, conducted 1,466 procedures through 2015
Stem Cell Therapy Availability in Malaysia: National Referral Centre for Hematological Expertise; performs approximately 180 transplants annually; reported survival outcomes of approximately 70% between 2010–2015
Stem Cell Transplant Quality in Malaysia: Government MOH hospital; approximately 200 procedures per year; leads government sector; cumulative caseload over 3,259 patients; hematology department staffed by at least four specialists; participates in Royal College of Pathologists of Australasia and UKNEQAS external quality assurance programs